Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
The Lancet. Diabetes & Endocrinology
|
March 7, 2024
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension study
Maud Robert, Tigran Poghosyan, Delphine Maucort-Boulch, et al.
Diabetes & Metabolism
|
May 10, 2026
Risk stratification of MASLD-related advanced fibrosis using a novel point-of-care device: the Hepatoscope
Cyrielle Caussy, Bruno Vergès, Fabien Subtil, et al.
Diabetes & Metabolism
|
February 19, 2025
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data
Emmanuel Disse, Judith Aron-Wisnewsky, David Jacobi, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
July 8, 2025
Delphi Consensus Among French Obesity Experts on Clinical Recommendations for Drug Prescription in Patients With Severe Obesity
Sarah Berdot, Germain Perrin, Emmanuel Disse, et al.
Cardiovascular Diabetology
|
June 14, 2025
Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort
Laurence Salle, Jean-Baptiste Julla, Guy Fagherazzi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 8, 2009
Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity
Ruben Nogueiras, Diego Pérez-Tilve, Christelle Veyrat-Durebex, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
July 25, 2020
A series of severe neurologic complications after bariatric surgery in France: the NEUROBAR Study
Maud Alligier, Anne-Laure Borel, Véronique Savey, et al.
Lancet (London, England)
|
March 11, 2019
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial
Maud Robert, Philippe Espalieu, Elise Pelascini, et al.
Diabetes Care
|
January 31, 2025
Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study
Cyrielle Caussy, Bruno Vergès, Damien Leleu, et al.
Diabetes, Obesity & Metabolism
|
March 26, 2026
SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials
Pierre Bel Lassen, David Jacobi, Marie-Claude Brindisi, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
The Lancet. Diabetes & Endocrinology
|
March 7, 2024
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension study
Maud Robert, Tigran Poghosyan, Delphine Maucort-Boulch, et al.
Diabetes & Metabolism
|
May 10, 2026
Risk stratification of MASLD-related advanced fibrosis using a novel point-of-care device: the Hepatoscope
Cyrielle Caussy, Bruno Vergès, Fabien Subtil, et al.
Diabetes & Metabolism
|
February 19, 2025
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data
Emmanuel Disse, Judith Aron-Wisnewsky, David Jacobi, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
July 8, 2025
Delphi Consensus Among French Obesity Experts on Clinical Recommendations for Drug Prescription in Patients With Severe Obesity
Sarah Berdot, Germain Perrin, Emmanuel Disse, et al.
Cardiovascular Diabetology
|
June 14, 2025
Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort
Laurence Salle, Jean-Baptiste Julla, Guy Fagherazzi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 8, 2009
Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity
Ruben Nogueiras, Diego Pérez-Tilve, Christelle Veyrat-Durebex, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
July 25, 2020
A series of severe neurologic complications after bariatric surgery in France: the NEUROBAR Study
Maud Alligier, Anne-Laure Borel, Véronique Savey, et al.
Lancet (London, England)
|
March 11, 2019
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial
Maud Robert, Philippe Espalieu, Elise Pelascini, et al.
Diabetes Care
|
January 31, 2025
Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study
Cyrielle Caussy, Bruno Vergès, Damien Leleu, et al.
Diabetes, Obesity & Metabolism
|
March 26, 2026
SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials
Pierre Bel Lassen, David Jacobi, Marie-Claude Brindisi, et al.
Page
of 8